These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8600636)

  • 1. Malignant melanoma in organ allograft recipients.
    Penn I
    Transplantation; 1996 Jan; 61(2):274-8. PubMed ID: 8600636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Melanoma in organ transplant patients].
    Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
    Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanomas in renal transplant recipients.
    Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
    Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma in a cohort of organ transplant recipients: Experience from a dedicated transplant dermatology clinic in Victoria, Australia.
    Maor D; Vajdic CM; Cumming S; Fahey V; Bala HR; Snaidr V; Brennand S; Goh MSY; Chong AH
    J Am Acad Dermatol; 2020 Sep; 83(3):773-779. PubMed ID: 31706934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary kidney tumors before and after renal transplantation.
    Penn I
    Transplantation; 1995 Feb; 59(4):480-5. PubMed ID: 7878750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
    Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
    Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
    Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
    Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo malignancy in pediatric organ transplant recipients.
    Penn I
    J Pediatr Surg; 1994 Feb; 29(2):221-6; discussion 227-8. PubMed ID: 8176596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous melanoma in solid organ transplant patients.
    Russo I; Piaserico S; Belloni-Fortina A; Alaibac M
    G Ital Dermatol Venereol; 2014 Aug; 149(4):389-94. PubMed ID: 25068225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
    Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
    Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo malignances in pediatric organ transplant recipients.
    Penn I
    Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant melanoma of the trunk: a retrospective review of 1128 patients.
    Ariel IM
    Cancer; 1982 Mar; 49(6):1070-8. PubMed ID: 7059934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational study on the mitotic rate and other prognostic factors in cutaneous primary melanoma arising from naevi and from melanoma de novo.
    Betti R; Santambrogio R; Cerri A; Vergani R; Moneghini L; Menni S
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1738-41. PubMed ID: 24673663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
    Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
    Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in the management of patients with melanoma.
    Lang PG
    Am J Clin Dermatol; 2002; 3(6):401-26. PubMed ID: 12113649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospective clinical study on new cutaneous melanomas in the Vendée area].
    Brisson C; Reynaud-Hautin C; Bure E; Chatal M; Hadet-Riegert M; Rafstedt P; Humeau S; Kerangueven J; Leroux E; Legroux J; Martin MP; Nogues M; Remond L; Ottavy N; Thebaud Y; Patarin M; Clement A; Proux M
    Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1125-8. PubMed ID: 14724515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of primary cutaneous melanomas of the hands and feet.
    Tseng JF; Tanabe KK; Gadd MA; Cosimi AB; Malt RA; Haluska FG; Mihm MC; Sober AJ; Souba WW
    Ann Surg; 1997 May; 225(5):544-50; discussion 550-3. PubMed ID: 9193182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage).
    Wanebo HJ; Woodruff J; Fortner JG
    Cancer; 1975 Mar; 35(3):666-76. PubMed ID: 1111935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
    Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
    Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.